AABB (formerly known as the American Association of Blood Banks) has installed Beth Shaz, MD, as its president for the 2019-2020 term. Shaz was inaugurated during the 2019 AABB Annual Meeting in San Antonio, Texas. She succeeds Michael Murphy, MD, FRCP, FRCPath, FFPath.
Shaz is the executive vice president and chief medical and scientific officer at the New York Blood Center (NYBC) in New York. She is responsible for all medical and scientific activities throughout the NYBC enterprises, including the Lindsey F. Kimball Research Institute, hemophilia service, transfusion services, cellular therapy, perioperative autologous transfusion and clinical apheresis. Additionally, she is leading NYBC’s Comprehensive Cell Solutions, which is focused on facilitating the next generation of cures in transfusion medicine and cell therapy.
An AABB member since 2002, Shaz has been involved in numerous Association committees and sections, including the Transfusion Medicine Section Coordinating Committee, the Accreditation Program Committee and the Blood Banks and Transfusion Services Standards Program Unit. Additionally, she chaired the Interorganizational Biovigilance Network Recipient Working Group, the Transfusion Services Accreditation Program Unit and the Blood Banking/Transfusion Medicine Fellowship Program Directors Group.
Shaz is a scientific member of Biomedical Excellence for Safer Transfusion, an Associate Editor of TRANSFUSION and an editorial board member of BLOOD. She received her medical degree from the University of Michigan Medical School and a Bachelor of Science degree in chemical engineering from Cornell University.